NextCure, Inc.
Hedge Funds Holdings
Last updated:
NextCure, Inc.‘s stocks are currently a part of 26 hedge funds’ portfolios, which represents 22.08% of the total amount of its stocks outstanding. This makes up a total of 6.12M shares of NextCure, Inc.. Compared to the previous quarter, the number fell by -54.25% or -7.26M shares fewer. As for the holding position changes, 15.38% (4) of current hedge fund investors increased the number of shares held, 42.31% (11) of current holders sold a part of the shares held, and 7.69% (2) closed the holdings completely. 4 hedge funds are new holders of NextCure, Inc. stock in Q1 2023, it is 15.38% of total holders.
Hedge funds holding NextCure (Q2 2019 – Q1 2023)
Q2 2019 | 43 |
---|---|
Q3 2019 | 52 |
Q4 2019 | 87 |
Q1 2020 | 81 |
Q2 2020 | 86 |
Q3 2020 | 74 |
Q4 2020 | 83 |
Q1 2021 | 92 |
Q2 2021 | 75 |
Q3 2021 | 68 |
Q4 2021 | 69 |
Q1 2022 | 56 |
Q2 2022 | 49 |
Q3 2022 | 48 |
Q4 2022 | 44 |
Q1 2023 | 26 |
Hedge funds changes in NextCure positions (Q2 2019 – Q1 2023)
Q2 2019 | 43 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q3 2019 | 16 | 15 | 13 | 6 | 2 |
Q4 2019 | 41 | 29 | 12 | 6 | -1 |
Q1 2020 | 11 | 29 | 25 | 15 | 1 |
Q2 2020 | 21 | 40 | 16 | 16 | -7 |
Q3 2020 | 13 | 23 | 24 | 24 | -10 |
Q4 2020 | 21 | 21 | 29 | 12 | 0 |
Q1 2021 | 22 | 23 | 33 | 12 | 2 |
Q2 2021 | 13 | 20 | 32 | 30 | -20 |
Q3 2021 | 6 | 19 | 29 | 13 | 1 |
Q4 2021 | 16 | 18 | 22 | 14 | -1 |
Q1 2022 | 3 | 22 | 15 | 16 | 0 |
Q2 2022 | 7 | 14 | 13 | 13 | 2 |
Q3 2022 | 5 | 13 | 14 | 6 | 10 |
Q4 2022 | 7 | 10 | 15 | 12 | 0 |
Q1 2023 | 4 | 4 | 11 | 2 | 5 |
Hedge funds changes in NextCure stock options (Q2 2019 – Q1 2023)
Q2 2019 | 0 | 0 |
---|---|---|
Q3 2019 | 0 | 0 |
Q4 2019 | 444,000 | 1,371,000 |
Q1 2020 | 0 | 2,299,000 |
Q2 2020 | 354,000 | 1,021,000 |
Q3 2020 | 1,262,000 | 633,000 |
Q4 2020 | 2,587,000 | 1,380,000 |
Q1 2021 | 1,729,000 | 3,083,000 |
Q2 2021 | 1,713,000 | 1,085,000 |
Q3 2021 | 627,000 | 295,000 |
Q4 2021 | 507,000 | 255,000 |
Q1 2022 | 246,000 | 258,000 |
Q2 2022 | 3,831,000 | 1,158,000 |
Q3 2022 | 1,112,000 | 687,000 |
Q4 2022 | 155,574 | 0 |
Q1 2023 | 139,000 | 0 |